Estudio nacional en Suecia | 10 JUL 19

Bypass gástrico reduce los casos nuevos de diabetes tipo 2

El objetivo de este estudio fue evaluar el impacto del bypass gástrico en Y de Roux sobre el tratamiento farmacológico de la diabetes de tipo 2
Autor/a: Backman OI, Bruze G, Naslund I, Ottosson J, Marsk R, Neovius M, Naslund E Ann Surg 2019; 269(5): 895-902
INDICE:  1. Página 1 | 2. Página 1
Página 1
  1. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387: 1377–1396.
  2. Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–2291.
  3. Collaboration NCDRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–1530.
  4. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122–1131.
  5. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2693.
  6. Puzziferri N, Roshek TB, 3rd. et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934–942.
  7. Dicker D, Yahalom R, Comaneshter DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg. 2016;26:1814–1820.
  8. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–973.
  9. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment. JAMA Surg. 2015;150:931.
  10. Keating C, Neovius M, Sjoholm K, et al. Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2015;3:855–865.
  11. Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA. 2012; 308:1132–1141.
  12. Cummings DE, Arterburn DE,Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59:945–953.
  13. Schauer PR,Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensivemedical therapy for diabetes: 3-year outcomes. N Engl J Med. 2014;370:2002–20
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024